advertisement
11.13.4 Betablocker and prostaglandin (23)
Showing records 1 to 23
Display all abstracts in classification 11.13.4 Betablocker and prostaglandin
Search within classification 11.13.4 Betablocker and prostaglandin60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Rossetti L
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Pfeiffer N
Advances in Therapy 2014; 31: 1228-1246
60147 Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
García-López A
BMC Ophthalmology 2014; 14: 161
60175 The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
Radcliffe NM
Clinical Ophthalmology 2014; 8: 2541-2549
60383 Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma
Holló G
Expert Opinion on Drug Safety 2015; 14: 609-617
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Traverso CE
Advances in Therapy 2014; 31: 1228-1246
60383 Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma
Katsanos A
Expert Opinion on Drug Safety 2015; 14: 609-617
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Sacchi M
BMC Ophthalmology 2015; 15: 7
60147 Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
Paczka JA; Jiménez-Román J
BMC Ophthalmology 2014; 14: 161
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Lorenz K
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Karabatsas CH
BMC Ophthalmology 2015; 15: 7
60147 Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
Hartleben C
BMC Ophthalmology 2014; 14: 161
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Topouzis F
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Saarela V; Liinamaa J
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Vetrugno M; Centofanti M
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Uusitalo H
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Boehm A
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Astakhov Y
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Vorwerk C
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Boiko E; Ropo A
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Goldblum D
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Fogagnolo P
BMC Ophthalmology 2015; 15: 7
